News | September 21, 2012

RadNet Joins GE Healthcare to Evaluate Breast Cancer Detection Processes

Study to evaluate model for improving the efficiency of the breast cancer detection process in the clinical practice setting

GE Healthcare RadNet Women's Healthcare Mammography Systems

September 21, 2012—GE Healthcare, a business division of General Electric Company, announced it is joining with RadNet, a network of outpatient diagnostic imaging centers, to pilot its Best Pathways initiative, a breast cancer detection optimization model. GE Healthcare and RadNet will evaluate the clinical breast cancer detection process to quantify inefficient diagnostic patterns and identify optimal paths to lower cost and improve patient outcomes. This program will focus on subpopulations of women in which guidelines are lacking and substantial variability is observed in clinical practice.

Best Pathways is designed to address a significant need for increased insight into the breast cancer detection process--from a patient’s initial screening mammogram to final biopsy. Historically, diagnostic processes have been variable and inefficient, leading to frequent false-positive test results and costly follow-up imaging procedures. In 2009, the U.S. Preventative Services Task Force (USPSTF) tightened recommendations for breast cancer screenings across multiple patient populations, citing lack of evidence supporting benefits and high cost of the screenings as primary factors.

“This initiative will provide deeper understanding of care patterns and ways to optimize processes to ensure the best outcomes for patients and operational efficiency for providers,” said Dr. Howard Berger, president and chief executive officer (CEO), RadNet. “With the technological and process expertise that GE Healthcare offers, as well as our shared passion for improving access to low-cost healthcare solutions, we look forward to improving care protocols in the detection of breast cancer.”

GE Healthcare and RadNet will identify and quantify diagnostic costs per cancer detected, the types of breast cancer detected and their stage distribution, the number of imaging tests and biopsies required to detect each cancer and the incremental cost-effectiveness ratios for each diagnostic case. Diagnostic patterns will be identified based on patient population characteristics including age, risk of developing breast cancer and breast density. The program will also seek to define optimal diagnostic paths for patient care based on rigorous data and analysis.

“Improving efficiency and outcomes in breast cancer detection supports our healthymagination commitment to delivering high-quality healthcare at a lower cost,” said David Lee, head of Health Economics and Reimbursement for GE Healthcare in the US and Canada. “We are pleased to work with RadNet to pilot our breast cancer detection optimization model in the clinical setting and look forward to identifying opportunities to improve the diagnosis and treatment of breast cancer while increasing efficiency and cost savings.”

GE Healthcare’s Best Pathways initiative was developed in collaboration with academic and community mammographers, primary care physicians and breast surgeons to explore alternative detection strategies and understand the need for new diagnostic technologies. Through its participation and eventual findings to be released publicly, RadNet will be able to refine and customize its breast cancer detection processes for its imaging centers for improved efficiency and better patient care.

For more information: www.radnet.com

 

 

Related Content

Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
The ASPIRE Cristalle FFDM system with DBT combines Fujifilm’s state-of-the-art hexagonal close pattern (HCP) detector design, advanced image processing and image acquisition workflow
News | Women's Health | August 01, 2017
Fujifilm Medical Systems U.S.A., Inc. announced that The Mammography Center of Monterey, an ACR-accredited breast...
Sponsored Content | Videos | Breast Imaging | July 28, 2017
Nancy Cappello, Ph.D., executive director and founder of Are You Dense Inc. and Are You Dense Advocacy, explains how
Radiotherapy Prior to Surgery Reduces Secondary Tumor Risk in Early-Stage Breast Cancer Patients
News | Radiation Therapy | July 24, 2017
Moffitt Cancer Center researchers launched a first-of-its-kind study comparing the long-term benefits of radiation...
Kubtec Launches New Website For Digital Imaging and Irradiation Products
News | Digital Radiography (DR) | July 20, 2017
Kubtec announced the launch a new website focused on the applications of digital X-ray imaging and irradiation for...
Volpara Solutions to Showcase Volpara Enterprise DDP Software at AHRA 2017
News | Mammography | July 11, 2017
Volpara Solutions Inc. will showcase its new Volpara Enterprise DDP software at the Association for Medical Imaging...
Fujifilm Showcases Digital Radiography, Mammography Innovations at AHRA 2017
News | Digital Radiography (DR) | July 06, 2017
Fujifilm Medical Systems U.S.A. Inc. will present its comprehensive portfolio of digital radiography (DR) and...
Feature | Breast Density | July 05, 2017 | By Nancy M. Cappello, Ph.D.
Two decades of research on the masking risk of dense breast tissue by mammography screening is indisputable. As the...
Solis Mammography Ranks No. 19 in Dallas Business Journal’s Middle Market 50
News | Mammography | June 30, 2017
June 30, 2017 — Solis Mammography was named the 19th fastest-growing, middle-market company in North Texas by the
GE Healthcare Announces First U.S. Installation of Senographe Pristina Mammography System
News | Mammography | June 29, 2017
GE Healthcare has collaborated with Boca Raton Regional Hospital (Boca Raton, Fla.) to bring a more comfortable...
Overlay Init